Pediatrix Medical Group, Inc. (MD) Quick Ratio
- Quick ratio · latest quarter: Value 1.26×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.26× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $631.80M ÷ $501.58M ≈ 1.26× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 631.80M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 501.58M USD | Liabilities, Current |
| Cash and equivalents | 288.88M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 115.32M USD | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 227.60M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $631.80M | $501.58M | $288.88M | $115.32M | $227.60M | (m) | 1.26× |
| 2026-03-31 | $553.77M | $442.64M | $205.78M | $123.19M | $224.80M | (m) | 1.25× |
| 2025-12-31 | $729.39M | $458.91M | $375.24M | $124.48M | $229.66M | (m) | 1.59× |
| 2025-09-30 | $694.22M | $392.55M | $340.06M | $123.04M | $231.12M | (m) | 1.77× |
| 2025-06-30 | $587.32M | $341.04M | $224.73M | $123.59M | $238.99M | (m) | 1.72× |
| 2025-03-31 | $461.70M | $271.05M | $98.98M | $120.20M | $242.53M | (m) | 1.70× |
| 2024-12-31 | $608.50M | $434.11M | $229.94M | $118.57M | $259.99M | (m) | 1.40× |
| 2024-09-30 | $507.35M | $373.08M | $103.83M | $116.62M | $286.90M | (m) | 1.36× |
| 2024-06-30 | $407.36M | $310.16M | $19.40M | $113.80M | $274.16M | (m) | 1.31× |
| 2024-03-31 | $399.22M | $247.28M | $8.00M | $107.47M | $283.75M | (m) | 1.61× |
| 2023-12-31 | $450.06M | $388.95M | $73.26M | $104.48M | $272.31M | (m) | 1.16× |
| 2023-09-30 | $402.07M | $350.44M | $21.18M | $103.54M | $277.35M | (m) | 1.15× |
| 2023-06-30 | $375.19M | $320.32M | $5.85M | $98.49M | $270.85M | (m) | 1.17× |
| 2023-03-31 | $381.57M | $284.22M | $6.12M | $96.71M | $278.74M | (m) | 1.34× |
| 2022-12-31 | $399.85M | $426.98M | $9.82M | $93.24M | $296.79M | (m) | 0.94× |
| 2022-09-30 | $394.42M | $351.69M | $8.67M | $91.40M | $294.35M | (m) | 1.12× |
| 2022-06-30 | $414.68M | $329.42M | $14.09M | $93.39M | $307.20M | (m) | 1.26× |
| 2022-03-31 | $414.37M | $269.73M | $7.18M | $89.58M | $317.62M | (m) | 1.54× |
| 2021-12-31 | $788.88M | $427.37M | $387.39M | $99.72M | $301.77M | (m) | 1.85× |
| 2021-09-30 | $718.40M | $397.56M | $357.91M | $98.51M | $261.97M | (m) | 1.81× |
| 2021-06-30 | $686.98M | $351.11M | $338.16M | $100.76M | $248.06M | (m) | 1.96× |
| 2021-03-31 | $616.18M | $326.96M | $269.63M | $100.81M | $245.74M | (m) | 1.88× |
| 2020-12-31 | $1.47B | $444.33M | $1.12B | $104.87M | $241.93M | (m) | 3.31× |
| 2020-09-30 | $643.21M | $488.36M | $294.51M | $81.57M | $267.13M | (m) | 1.32× |
| 2020-06-30 | $568.48M | $383.93M | $132.15M | $90.64M | $345.68M | (m) | 1.48× |
| 2020-03-31 | (m) | $346.40M | $312.15M | (m) | $476.99M | (m) | (m) |
| 2019-12-31 | $686.15M | $541.82M | $112.77M | $74.51M | $498.87M | (m) | 1.27× |
| 2019-09-30 | $601.96M | $500.79M | $28.89M | $78.37M | $494.70M | (m) | 1.20× |
| 2019-06-30 | $611.51M | $441.05M | $24.48M | $82.83M | $504.19M | (m) | 1.39× |
| 2019-03-31 | $635.34M | $415.18M | $26.48M | $86.22M | $522.64M | (m) | 1.53× |
| 2018-12-31 | (m) | $500.19M | $36.74M | (m) | $542.27M | (m) | (m) |
| 2018-09-30 | (m) | $435.94M | $34.46M | (m) | $522.83M | (m) | (m) |
| 2018-06-30 | (m) | $411.21M | $38.06M | (m) | $528.00M | (m) | (m) |
| 2018-03-31 | (m) | $356.99M | $40.94M | (m) | $542.61M | (m) | (m) |
| 2017-12-31 | (m) | $531.42M | $60.20M | (m) | $504.00M | (m) | (m) |
| 2017-09-30 | (m) | $475.99M | $48.40M | (m) | $520.01M | (m) | (m) |
| 2017-06-30 | (m) | $350.15M | $40.42M | (m) | $480.40M | (m) | (m) |
| 2017-03-31 | (m) | $328.61M | $41.84M | (m) | $487.69M | (m) | (m) |
| 2016-12-31 | (m) | $448.95M | $55.70M | (m) | $495.28M | (m) | (m) |
| 2016-09-30 | (m) | $413.03M | $52.80M | (m) | $486.96M | (m) | (m) |
| 2016-06-30 | (m) | $332.10M | $51.89M | (m) | $461.16M | (m) | (m) |
| 2016-03-31 | (m) | $312.74M | $55.49M | (m) | $465.83M | (m) | (m) |
| 2015-12-31 | (m) | $428.77M | $51.57M | (m) | $444.74M | (m) | (m) |
| 2015-09-30 | (m) | $404.57M | $60.91M | (m) | $406.76M | (m) | (m) |
| 2015-06-30 | (m) | $311.81M | $65.32M | (m) | $380.55M | (m) | (m) |
| 2015-03-31 | (m) | $267.43M | $50.22M | (m) | $360.87M | (m) | (m) |
| 2014-12-31 | (m) | $416.27M | $47.93M | (m) | $352.19M | (m) | (m) |
| 2014-09-30 | (m) | $329.28M | $71.82M | (m) | $345.17M | (m) | (m) |
| 2014-06-30 | (m) | $262.81M | $17.71M | (m) | $327.41M | (m) | (m) |
| 2014-03-31 | (m) | $222.19M | $19.77M | (m) | $315.69M | (m) | (m) |
| 2013-12-31 | (m) | $326.79M | $31.14M | (m) | $285.40M | (m) | (m) |
| 2013-09-30 | (m) | $273.99M | $16.24M | (m) | $272.81M | (m) | (m) |
| 2013-06-30 | (m) | $212.77M | $13.16M | (m) | $269.77M | (m) | (m) |
| 2013-03-31 | (m) | $190.90M | $34.42M | (m) | $263.82M | (m) | (m) |
| 2012-12-31 | (m) | $268.34M | $21.28M | (m) | $248.07M | (m) | (m) |
| 2012-09-30 | (m) | $244.88M | $66.12M | (m) | $250.51M | (m) | (m) |
| 2012-06-30 | (m) | $197.21M | $12.15M | (m) | $240.92M | (m) | (m) |
| 2012-03-31 | (m) | $172.87M | $22.39M | (m) | $236.72M | (m) | (m) |
| 2012-01-03 | (m) | (m) | $18.60M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $254.30M | $18.60M | (m) | $230.39M | (m) | (m) |
| 2011-09-30 | (m) | $215.07M | $35.75M | (m) | $207.06M | (m) | (m) |
| 2011-06-30 | (m) | $174.80M | $23.96M | (m) | $194.03M | (m) | (m) |
| 2011-03-31 | (m) | $149.68M | $15.05M | (m) | $188.17M | (m) | (m) |
| 2010-12-31 | (m) | $320.85M | $26.25M | (m) | $181.40M | (m) | (m) |
| 2010-09-30 | (m) | $311.24M | $61.39M | (m) | $174.72M | (m) | (m) |
| 2010-06-30 | (m) | $285.35M | $26.14M | (m) | $178.98M | (m) | (m) |
| 2010-03-31 | (m) | (m) | $23.94M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $346.70M | $26.50M | (m) | $164.44M | (m) | (m) |
| 2009-09-30 | (m) | (m) | $20.86M | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | $18.60M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $14.35M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $102.84M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |